BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 2599125)

  • 1. Prolonged venous access in cancer patients.
    Guenier C; Ferreira J; Pector JC
    Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Broviac/Hickman catheter for long-term venous access in pediatric cancer patients.
    Yokoyama S; Fujimoto T; Tajima T; Mitomi T; Yabe H; Kato S
    Jpn J Clin Oncol; 1988 Jun; 18(2):143-8. PubMed ID: 3132566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Permanent central venous catheters in oncologic patients].
    Schrøder M; Pedersen IR; Rasmussen RB
    Ugeskr Laeger; 1991 Sep; 153(36):2491-4. PubMed ID: 1926604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of Hickman line- and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy.
    Ng F; Mastoroudes H; Paul E; Davies N; Tibballs J; Hochhauser D; Mayer A; Begent R; Meyer T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):551-6. PubMed ID: 17517500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
    Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
    Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous chamber systems (ports) for long-term care in cancer patients].
    Hájek R; Sevcík P; Ondrásek J; Mayer J; Vásová I; Král Z; Tomíska M; Krahulcová E; Penka M; Kubesová H
    Vnitr Lek; 1995 Jan; 41(1):21-7. PubMed ID: 7716888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implanted venous access system in oncology. Review of 296 cases].
    Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
    Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Port-A-Cath infections in children with cancer.
    Hengartner H; Berger C; Nadal D; Niggli FK; Grotzer MA
    Eur J Cancer; 2004 Nov; 40(16):2452-8. PubMed ID: 15519519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
    Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
    J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
    De Backer A; Vanhulle A; Otten J; Deconinck P
    Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with minimal complications in implanted catheters in children.
    Hockenberry MJ; Schultz WH; Bennett B; Bryant R; Falletta JM
    Am J Pediatr Hematol Oncol; 1989; 11(3):295-9. PubMed ID: 2782556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with a modified implantation technique of Port-A-Cath systems as continuous venous access in infants and children].
    Erhard J; Lange R; Kremens B; Krause U; Eigler FW
    Med Klin (Munich); 1991 Oct; 86(10):512-4. PubMed ID: 1758373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripherally inserted central venous catheters. Low-risk alternatives for ongoing venous access.
    Merrell SW; Peatross BG; Grossman MD; Sullivan JJ; Harker WG
    West J Med; 1994 Jan; 160(1):25-30. PubMed ID: 8128698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central venous access ports in children treated for hematopoietic malignancies.
    Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
    Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience at a single institution with endovascular treatment of mechanical complications caused by implanted central venous access devices in pediatric and adult patients.
    Bessoud B; de Baere T; Kuoch V; Desruennes E; Cosset MF; Lassau N; Roche A
    AJR Am J Roentgenol; 2003 Feb; 180(2):527-32. PubMed ID: 12540466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
    Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
    Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-centre experience with tunnelled central venous catheters in 150 cancer patients.
    Koolen DA; van Laarhoven HW; Wobbes T; Punt CJ
    Neth J Med; 2002 Nov; 60(10):397-401. PubMed ID: 12607590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous catheters for chemotherapy of solid tumors--our results in the last 5 years.
    Zganjer M; Cizmić A; Butković D; Matolić M; Karaman-Ilić M; Stepan J
    Coll Antropol; 2008 Sep; 32(3):767-70. PubMed ID: 18982750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.